Jim Pavliska joined Nuvaira in January 2013 and brings more than 15 years of clinical research experience to the position. His broad research expertise and passion for human research bring valuable insight to the clinical program at Nuvaira.
Prior to joining Nuvaira, Mr. Pavliska was the Clinical Director at Lutonix, Inc. for four years (acquired by CR Bard, Inc. in 2011). His responsibilities included overseeing pre-clinical and clinical research, including study design, FDA & IRB/EC approvals, and study execution for a drug-coated balloon catheter. Mr. Pavliska began his research experience at Brigham & Women’s in Boston coordinating interventional research. He joined start-up, PercuSurge (later acquired by Medtronic) in 1998 to manage field research activities. He then went on to spend seven years at Velocimed/St. Jude building the clinical program as Clinical Research Director and later as Director of Interventional Research after the acquisition.
Mr. Pavliska holds a Bachelor of Science degree in Biomedical Science from Texas A&M University.